Inflammatory cytokine release inhibitor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 17, 2012
Grant Date -
Oct 28, 2010
app pub date -
Jul 2, 2010
filing date -
Dec 18, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A medicament having inhibitory activity against NF-κB activation, which comprises a compound represented by the following general formula (I) or a pharmacologically acceptable salt as an active ingredient:wherein X represents a connecting group, A represents hydrogen atom or acetyl group, E represents an aryl group or a heteroaryl group, and ring X represents an arene or a heteroarene.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully